Grasustek (pegfilgrastim biosimilar) / USV Biologics - LARVOL DELTA

UPMC expert discusses price variation for biosimilars (AJMC) - "Brufsky admits that finding this out was an eye-opener for him. 'It's a very complicated process for the pharmacy, the pharmacy and therapeutics committee, and the financial team to figure out exactly what the benefits of a biosimilar are financially. It really depends on a lot of factors that you ordinarily wouldn't have thought of.'...The goal for many in the health-care system is to figure out what the biosimilar threshold is that represents the perfect balance of cost savings and convenience, he said."

Media quote